Table 4.
Symptom | Extent of problem, n (%) |
|||
Platinum–fluorouracil + cetuximab (n = 152) |
Platinum–fluorouracil alone (n = 137) |
|||
None at all/a little | Quite a bit/very much | None at all/a little | Quite a bit/very much | |
Problems with teeth | 83 (55) | 16 (11) | 61 (45) | 11 (8) |
Problems with opening mouth | 68 (45) | 33 (22) | 48 (35) | 27 (20) |
Dry mouth | 58 (38) | 44 (29) | 46 (34) | 30 (22) |
Sticky saliva | 50 (33) | 50 (33) | 35 (26) | 40 (29) |
Coughing | 83 (55) | 19 (13) | 46 (34) | 28 (20) |
Feeling ill | 74 (49) | 28 (18) | 50 (36) | 25 (18) |
EORTC QLQ-H&N35, European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Head and Neck 35.